7471 - 7480 of 9034 Results
Title
Year
-
OPENTitle: GPNMB confers risk for Parkinson’s disease through interaction with α-synucleinJournal Name: SciencePublisher: American Association for the Advancement of Science (AAAS)Vol: 377Issue #: 6608Start Page: eabk0637End Page: eabk0637Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1126/science.abk0637Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/9870036Citation Count: 144
-
OPENTitle: Disease specific and nonspecific metabolic brain networks in behavioral variant of frontotemporal dementiaJournal Name: Human Brain MappingPublisher: WileyVol: 44Issue #: 3Start Page: 1079End Page: 1093Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/hbm.26140Best OA location URL: https://doi.org/10.1002/hbm.26140Citation Count: 14
-
OPENTitle: Time-resolved RNA signatures of CD4+ T cells in Parkinson’s diseaseJournal Name: Cell Death DiscoveryPublisher: Springer Science and Business Media LLCVol: 9Issue #: 1Start Page: 18End Page: 18Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41420-023-01333-0Best OA location URL: https://www.nature.com/articles/s41420-023-01333-0.pdfCitation Count: 10
-
OPENTitle: LUBAC assembles a ubiquitin signaling platform at mitochondria for signal amplification and transport of NF‐κB to the nucleusJournal Name: The EMBO JournalPublisher: Springer Science and Business Media LLCVol: 41Issue #: 24Start Page: e112006End Page: e112006Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.15252/embj.2022112006Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.15252/embj.2022112006Citation Count: 35
-
OPENTitle: Cognitive-Driven Activities of Daily Living Impairment as a Predictor for Dementia in Parkinson DiseaseJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 99Issue #: 23Start Page: e2548End Page: e2560Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1212/wnl.0000000000201201Best OA location URL: https://n.neurology.org/content/neurology/99/23/e2548.full.pdfCitation Count: 26
-
OPENTitle: Incidence of Parkinson disease in North AmericaJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 8Issue #: 1Start Page: 170End Page: 170Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-022-00410-yBest OA location URL: https://www.nature.com/articles/s41531-022-00410-y.pdfCitation Count: 315
-
OPENTitle: Interfacility Transfers for Seizure-Related Emergencies in the United StatesJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 99Issue #: 24Start Page: e2718End Page: e2727Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1212/wnl.0000000000201319Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/9757868Citation Count: 9
-
OPENTitle: Identification and prediction of Parkinson’s disease subtypes and progression using machine learning in two cohortsJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 8Issue #: 1Start Page: 172End Page: 172Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-022-00439-zBest OA location URL: https://www.nature.com/articles/s41531-022-00439-z.pdfCitation Count: 105
- Older patients with COVID‐19 and neuropsychiatric conditions: A study of risk factors for mortality2022OPENTitle: Older patients with COVID‐19 and neuropsychiatric conditions: A study of risk factors for mortalityJournal Name: Brain and BehaviorPublisher: WileyVol: 12Issue #: 12Start Page: e2787End Page: e2787Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/brb3.2787Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/brb3.2787Citation Count: 2
-
OPENTitle: ApoJ/Clusterin concentrations are determinants of cerebrospinal fluid cholesterol efflux capacity and reduced levels are associated with Alzheimer’s diseaseJournal Name: Alzheimer's Research & TherapyPublisher: Springer Science and Business Media LLCVol: 14Issue #: 1Start Page: 194End Page: 194Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s13195-022-01119-zBest OA location URL: https://alzres.biomedcentral.com/counter/pdf/10.1186/s13195-022-01119-zCitation Count: 19